Santhera Pharmaceuticals Holding AG
OTC:SPHDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
OTC:SPHDF
|
CH |
|
Cognor Holding SA
F:WO9
|
PL |
|
C
|
Canadian Uranium Corp
OTC:CANUF
|
CA |
|
D
|
DeFi Development Corp
XMUN:F6S0
|
US |
Wall Street
Price Targets
SPHDF Price Targets Summary
Santhera Pharmaceuticals Holding AG
According to Wall Street analysts, the average 1-year price target for SPHDF is 37.25 USD with a low forecast of 36.89 USD and a high forecast of 38.35 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SPHDF's stock price target?
Price Target
37.25
USD
According to Wall Street analysts, the average 1-year price target for SPHDF is 37.25 USD with a low forecast of 36.89 USD and a high forecast of 38.35 USD.
What is Santhera Pharmaceuticals Holding AG's Revenue forecast?
Projected CAGR
60%
For the last 13 years the compound annual growth rate for Santhera Pharmaceuticals Holding AG's revenue is 21%. The projected CAGR for the next 3 years is 60%.
